{"id":34747,"date":"2026-03-19T17:57:00","date_gmt":"2026-03-19T12:27:00","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=34747"},"modified":"2026-03-19T15:58:32","modified_gmt":"2026-03-19T10:28:32","slug":"medtech-news-for-minimed-spinal-elements-mindray","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/medtech-news-for-minimed-spinal-elements-mindray","title":{"rendered":"MiniMed Secures FDA Clearance for MiniMed Flex; Spinal Elements Expands Portfolio with FDA-Cleared Ventana\u00ae Platform and Initial ALIF Launch; Mindray North America Strengthens Respiratory Care Offering Through Ventilator Market Entry; Micro-Tech Endoscopy Enters Definitive Deal to Acquire Key GI Product Lines from CONMED; Composite Manufacturing Inc. Unveils Study Showing NekSpine\u00ae Exoskeleton Eases Neck and Back Load During Simulated Surgeries; SkinVision Partners on Landmark Trial to Expand Dermatology Care Access in the U.S."},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_76 counter-hierarchy ez-toc-counter ez-toc-white ez-toc-container-direction\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<label for=\"ez-toc-cssicon-toggle-item-69fd778a2a171\" class=\"ez-toc-cssicon-toggle-label\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/label><input type=\"checkbox\"  id=\"ez-toc-cssicon-toggle-item-69fd778a2a171\"  aria-label=\"Toggle\" \/><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.delveinsight.com\/blog\/medtech-news-for-minimed-spinal-elements-mindray\/#MiniMed_Announced_the_FDA_Clearance_of_MiniMed_Flex%E2%84%A2_the_Companys_Smallest_Insulin_Pump_Featuring_its_First_Smartphone-Controlled_Design\" >MiniMed Announced the FDA Clearance of MiniMed Flex\u2122, the Company&#8217;s Smallest Insulin Pump Featuring its First Smartphone-Controlled Design&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.delveinsight.com\/blog\/medtech-news-for-minimed-spinal-elements-mindray\/#Spinal_Elements_Expanded_Ventana%C2%AE_Platform_with_FDA_510k_Clearance_and_First_Cases_of_Ventana%C2%AE_A_ALIF_System\" >Spinal Elements Expanded Ventana\u00ae Platform with FDA 510(k) Clearance and First Cases of Ventana\u00ae A ALIF System<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.delveinsight.com\/blog\/medtech-news-for-minimed-spinal-elements-mindray\/#Mindray_North_America_Revolutionized_Respiratory_Care_with_Landmark_Entry_into_the_Ventilator_Market\" >Mindray North America Revolutionized Respiratory Care with Landmark Entry into the Ventilator Market&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.delveinsight.com\/blog\/medtech-news-for-minimed-spinal-elements-mindray\/#Micro-Tech_Endoscopy_Signed_Definitive_Agreement_to_Acquire_Duraclip%E2%84%A2_Precisor%C2%AE_and_Optibite%C2%AE_Product_Lines_from_CONMED\" >Micro-Tech Endoscopy Signed Definitive Agreement to Acquire Duraclip\u2122, Precisor\u00ae, and Optibite\u00ae Product Lines from CONMED&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.delveinsight.com\/blog\/medtech-news-for-minimed-spinal-elements-mindray\/#Composite_Manufacturing_Inc_Announced_that_the_new_Study_Showed_NekSpine%C2%AE_Exoskeleton_Significantly_Reduces_Neck_and_Back_Strain_in_Simulated_Surgical_Tasks\" >Composite Manufacturing Inc. Announced that the new Study Showed NekSpine\u00ae Exoskeleton Significantly Reduces Neck and Back Strain in Simulated Surgical Tasks&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/www.delveinsight.com\/blog\/medtech-news-for-minimed-spinal-elements-mindray\/#SkinVision_Collaborated_on_Pivotal_Trial_to_Improve_Access_to_Dermatology_Care_in_the_United_States\" >SkinVision Collaborated on Pivotal Trial to Improve Access to Dermatology Care in the United States&nbsp;<\/a><\/li><\/ul><\/nav><\/div>\n\n<h2 class=\"wp-block-heading\" id=\"h-minimed-announced-the-fda-clearance-of-minimed-flex-the-company-s-smallest-insulin-pump-featuring-its-first-smartphone-controlled-design-nbsp\"><span class=\"ez-toc-section\" id=\"MiniMed_Announced_the_FDA_Clearance_of_MiniMed_Flex%E2%84%A2_the_Companys_Smallest_Insulin_Pump_Featuring_its_First_Smartphone-Controlled_Design\"><\/span><strong>MiniMed Announced the FDA Clearance of MiniMed Flex\u2122, the Company&#8217;s Smallest Insulin Pump Featuring its First Smartphone-Controlled Design&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>On 18 March 2026, MiniMed announced that it had received clearance from the U.S. Food and Drug Administration (FDA) for its MiniMed Flex\u2122, a next-generation, discreet insulin pump designed for seamless integration into daily life. The device was introduced as the company\u2019s first screenless, smartphone-controlled insulin pump, developed in collaboration with people living with diabetes to enhance usability and convenience. Approximately half the size of the MiniMed\u2122 780G system and comparable to two stacked insulin vials, the MiniMed Flex\u2122 featured a compact design with a 300-unit insulin reservoir, allowing flexibility in wear and supporting diverse insulin needs.<\/p>\n\n\n\n<p>The system was powered by MiniMed\u2019s advanced SmartGuard\u2122 algorithm with Meal Detection\u2122 technology, which had demonstrated strong clinical performance in maintaining glucose levels within the recommended Time in Range. It was also designed to be compatible with the company\u2019s latest sensor portfolio, including the Simplera Sync\u2122 sensor and sensors developed by Abbott Laboratories. Additionally, the pump supported extended infusion set options, including the Extended\u2122 infusion set, enabling up to seven days of wear and significantly reducing the frequency of injections compared to traditional insulin therapy.<\/p>\n\n\n\n<p>The company also introduced the MiniMed\u2122 Forward Program, allowing users of the MiniMed\u2122 780G system to upgrade to the MiniMed Flex\u2122 system at no additional cost once commercially available. The launch strategy included an initial customer experience phase with select users, followed by a broader commercial rollout in the United States. The device was cleared for individuals aged 7 years and older with type 1 diabetes and for adults with insulin-requiring type 2 diabetes, marking a significant advancement in automated insulin delivery and patient-centric diabetes management.<\/p>\n\n\n\n<p><em>&#8220;At MiniMed, our Mission is to make every day a better day for people with diabetes,&#8221; said Que Dallara, chief executive officer of MiniMed. &#8220;MiniMed Flex\u2122 embodies that promise. It&#8217;s designed to work quietly and reliably in the background advanced automation wrapped in a compact, smartphone\u2011controlled pump. The result is technology that lets people spend less time managing diabetes and more time living their lives. Securing FDA clearance for our first product as a standalone, public company just one week after our IPO marks a major milestone and underscores our commitment to delivering the breakthrough innovation our customers deserve.&#8221;<\/em><\/p>\n\n\n\n<p>As per DelveInsight\u2019s \u201c<a href=\"https:\/\/www.delveinsight.com\/report-store\/insulin-infusion-pumps-market\"><strong>Insulin Infusion Pumps Market Report<\/strong><\/a>,\u201d the global insulin infusion pumps market was valued at <strong>USD 6.48 billion<\/strong> in 2023, growing at a <strong>CAGR of 8.69%<\/strong> during the forecast period from 2024 to 2030 to reach <strong>USD 10.68 billion<\/strong> by 2030. The insulin infusion pumps market is slated to witness prosperity owing to factors such as growing prevalence of diabetes, increasing sedentary lifestyle, growing aging population base which is susceptible to the development of diabetes, and the growing focus on improving the safety and usability of insulin infusion pumps are further expected to result in the appreciable revenue growth in the insulin infusion pumps market during the forecast period from 2024 to 2030.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-spinal-elements-expanded-ventana-platform-with-fda-510-k-clearance-and-first-cases-of-ventana-a-alif-system\"><span class=\"ez-toc-section\" id=\"Spinal_Elements_Expanded_Ventana%C2%AE_Platform_with_FDA_510k_Clearance_and_First_Cases_of_Ventana%C2%AE_A_ALIF_System\"><\/span><strong>Spinal Elements Expanded Ventana\u00ae Platform with FDA 510(k) Clearance and First Cases of Ventana\u00ae A ALIF System<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>On 18 March 2026, Spinal Elements\u00ae, a spine technology company focused on innovative surgical solutions, announced that it had received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and had successfully performed the first clinical cases using its Ventana A Anterior Lumbar Interbody Fusion (ALIF) System. The launch strengthened the company\u2019s portfolio of 3D-printed titanium interbody implants for both lumbar and cervical fusion procedures and was introduced through a limited market rollout.<\/p>\n\n\n\n<p>The Ventana A system was designed to enhance fusion outcomes by supporting improved surgical performance and efficiency. It featured a unique hinged implant architecture intended to maximize bone graft volume and maintain graft containment during implantation. Manufactured using a specialized 3D printing process, the system enabled better restoration of segmental alignment and spinal stability. Additionally, it incorporated reduced titanium density to optimize load sharing, thereby helping to mitigate the risk of subsidence while also improving intraoperative visualization for surgeons.&nbsp;<\/p>\n\n\n\n<p><em>\u201cALIF is a powerful procedure and a workhorse for many spine surgeons, which is why we set out to develop a best-in-class system that maximizes its clinical benefits,\u201d said Ron Lloyd, Chief Executive Officer. \u201cBuilding on the proven Ventana platform, this contemporary system increases Spinal Elements\u2019 portfolio offering and procedural reach to a greater number of surgeon and distribution partners. Combined with intuitive instrumentation and efficient packaging, Ventana A is designed to enhance clinical performance and operating room efficiency, demonstrating our commitment to continued innovation \u2013 working with surgeon partners to develop systems that are meaningfully differentiated and deliver improved outcomes\u201d.<\/em><\/p>\n\n\n\n<p>The first case was performed by Dr. A.J. Rush III at Texas Spine Consultants in Addison, TX. Dr. Rush shared: \u201cThe Ventana A system delivers a clinical advantage to everyday challenges for spine surgeons. The large graft window allows for maximal graft delivery as well as improved visualization for fusion assessment and distributes load across the entire surface to reduce subsidence risk. Having used the instrumentation in both lab and clinical settings, I can attest to Ventana A\u2019s ability to offer a best in class ALIF solution.\u201d<\/p>\n\n\n\n<p>As per DelveInsight\u2019s \u201c<a href=\"https:\/\/www.delveinsight.com\/report-store\/spinal-fusion-devices-market\"><strong>Spinal Fusion Devices Market Report<\/strong><\/a>,\u201d the global spinal fusion devices market size is expected to increase from <strong>USD 7,139.71 million<\/strong> in 2024 to <strong>USD 10,762.88 million<\/strong> by 2032, growing at a <strong>CAGR of 5.31%<\/strong> during the forecast period from 2025 to 2032. The spinal fusion devices market is witnessing steady growth, driven by several key factors. Increasing instances of spinal disorders, such as degenerative disc disease, spinal stenosis, and vertebral fractures, have significantly raised the demand for surgical interventions that provide spinal stability and pain relief. The rising adoption of biologics in spinal fusion procedures is further enhancing bone healing and fusion success rates, making these devices more effective and attractive to surgeons. Lifestyle-related factors, including growing sedentary habits and obesity, are contributing to higher risks of disc degeneration and spinal instability, which in turn fuels the need for spinal fusion solutions. Additionally, intensified product development activities by leading market players are introducing advanced implants with improved design, materials, and minimally invasive options, supporting broader adoption. These drivers, combined with technological innovations and increasing clinical awareness, continue to propel the expansion of the spinal fusion devices market globally.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-mindray-north-america-revolutionized-respiratory-care-with-landmark-entry-into-the-ventilator-market-nbsp\"><span class=\"ez-toc-section\" id=\"Mindray_North_America_Revolutionized_Respiratory_Care_with_Landmark_Entry_into_the_Ventilator_Market\"><\/span><strong>Mindray North America Revolutionized Respiratory Care with Landmark Entry into the Ventilator Market&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>On 18 March 2026, Mindray, a global leader in healthcare innovation across perioperative care, medical imaging, and critical care, announced its entry into the ventilator market with the launch of the SV900 and SV700 ventilators. As one of the world\u2019s largest providers of acute care hospital ventilators, the company leveraged its global expertise to establish a strong presence in the North American market. This strategic expansion broadened its critical care portfolio by offering clinicians adaptable, flexible, and efficient respiratory support technologies designed for high-pressure clinical environments.<\/p>\n\n\n\n<p>The SV900 and SV700 ventilators were developed to support patients of all ages and varying respiratory needs across different care settings. They integrated invasive, non-invasive, and high-flow oxygen therapies into a single platform, thereby streamlining clinical workflows and ensuring appropriate respiratory support throughout the patient recovery process. Additionally, the systems incorporated advanced tools for weaning and lung-protective ventilation strategies, which enhanced clinical decision-making and contributed to improved patient outcomes.<\/p>\n\n\n\n<p>Both ventilators were supported by a three-year warranty, reflecting the company\u2019s commitment to long-term value and reliability. This warranty was part of a broader total cost of ownership approach, ensuring that healthcare providers received consistent service, support, and operational efficiency beyond initial installation. Overall, Mindray\u2019s entry into the ventilator segment represented a significant step in expanding access to advanced respiratory care solutions and reinforced its focus on driving innovation in critical care.<\/p>\n\n\n\n<p><em>&#8220;Entering the U.S. ventilator market with the SV900 and SV700 represents a pivotal moment in our company&#8217;s growth and commitment to healthcare providers,&#8221; said Wayne Quinn, President of Mindray North America. \u201cWe are enabling our partners to achieve significant economies of scale, streamline procurement processes, and enhance patient care by integrating our new respiratory solutions into our critical care portfolio and equipping their teams with a full suite of cutting-edge tools from a single, trusted provider.&#8221;<\/em><\/p>\n\n\n\n<p>As per DelveInsight\u2019s \u201c<a href=\"https:\/\/www.delveinsight.com\/report-store\/ventilators-market\"><strong>Ventilators Market Report<\/strong><\/a>,\u201d the global ventilators market is expected to grow at a <strong>CAGR of 11.65%<\/strong> during the forecast period from 2024 to 2032. The Ventilators market is expected to witness substantial growth, fueled by several important factors. Primarily, the increasing prevalence of respiratory and cardiovascular diseases serves as a major growth driver. Conditions such as chronic obstructive pulmonary disease (COPD), asthma, acute myocardial infarction, congestive heart failure exacerbations, severe arrhythmias, and cardiogenic shock create a rising demand for advanced ventilator support. Additionally, the expansion of critical care units significantly contributes to the market\u2019s growth.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-micro-tech-endoscopy-signed-definitive-agreement-to-acquire-duraclip-precisor-and-optibite-product-lines-from-conmed-nbsp\"><span class=\"ez-toc-section\" id=\"Micro-Tech_Endoscopy_Signed_Definitive_Agreement_to_Acquire_Duraclip%E2%84%A2_Precisor%C2%AE_and_Optibite%C2%AE_Product_Lines_from_CONMED\"><\/span><strong>Micro-Tech Endoscopy Signed Definitive Agreement to Acquire Duraclip\u2122, Precisor\u00ae, and Optibite\u00ae Product Lines from CONMED&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>On 18 March 2026, Micro-Tech Endoscopy announced that it had entered into a definitive agreement to acquire the global distribution rights for the Duraclip\u2122, Precisor\u00ae, and Optibite\u00ae product lines from CONMED Corporation. These products had previously been distributed by CONMED on behalf of Micro-Tech for more than a decade. The agreement followed CONMED\u2019s strategic decision to exit the gastroenterology segment as part of a broader portfolio realignment.<\/p>\n\n\n\n<p>Through this transaction, Micro-Tech integrated these product lines into its gastrointestinal (GI) endoscopy portfolio, ensuring continued availability for clinicians. The addition of Duraclip\u2122 strengthened its hemostasis product portfolio, while Precisor\u00ae and Optibite\u00ae expanded its biopsy device offerings. Combined with its existing range of diagnostic and therapeutic solutions, including the Dual Action Tissue (DAT) Closure device and the eyeMAX cholangioscopy system, the company further enhanced its ability to address clinical needs across both ambulatory surgical centers and hospital settings.&nbsp;<\/p>\n\n\n\n<p><em>\u201cThis agreement reflects our continued commitment to expanding access to a broad range of GI endoscopy tools,\u201d said Scott VanderMeer, President of Micro-Tech Endoscopy Americas. \u201cBy adding Duraclip, Precisor, and Optibite to our portfolio, we are strengthening our position in the GI market and reinforcing our role as a trusted partner to clinicians.\u201d<\/em><\/p>\n\n\n\n<p><em>\u201cWe are pleased to transition these product lines from CONMED to Micro-Tech and believe they are well positioned to continue the strong legacy these products have established in the GI market,\u201d said Pete Shagory, Vice President &amp; General Manager, Advanced Endoscopic Technologies at CONMED. \u201cMicro-Tech has long served as the original manufacturer behind the Duraclip, Precisor, and Optibite devices and brings extensive experience in its design and production. We are committed to supporting a smooth transition for customers.\u201d<\/em><\/p>\n\n\n\n<p>According to DelveInsight\u2019s \u201c<a href=\"https:\/\/www.delveinsight.com\/report-store\/endoscopes-market\"><strong>Endoscopes Market Report<\/strong><\/a>,\u201d the global endoscopes market was valued at <strong>USD 12.95 billion<\/strong> in 2023, growing at a<strong> CAGR of 6.05%<\/strong> during the forecast period from 2024 to 2030 to reach <strong>USD 18.32 billion<\/strong> by 2030. The increase in demand for endoscopes is primarily attributed to the increasing prevalence of chronic disease which require the use of endoscopes for diagnosis, such as some gastrointestinal diseases like irritable bowel syndrome (IBD), gastroesophageal reflux disease (GERD), peptic ulcer disease, and crohn&#8217;s disease, increase in number of geriatric population who are more prone to chronic ailments, increasing awareness and demand of minimally invasive surgeries and no blood loss surgery, and rise in technological advancements in endoscopes like image magnification, high-definition optical systems and digital imaging are anticipated to bolster the market, thereby contributing to the growth of the endoscopes market during the forecast period from 2024 to 2030.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-composite-manufacturing-inc-announced-that-the-new-study-showed-nekspine-exoskeleton-significantly-reduces-neck-and-back-strain-in-simulated-surgical-tasks-nbsp\"><span class=\"ez-toc-section\" id=\"Composite_Manufacturing_Inc_Announced_that_the_new_Study_Showed_NekSpine%C2%AE_Exoskeleton_Significantly_Reduces_Neck_and_Back_Strain_in_Simulated_Surgical_Tasks\"><\/span><strong>Composite Manufacturing Inc. Announced that the new Study Showed NekSpine\u00ae Exoskeleton Significantly Reduces Neck and Back Strain in Simulated Surgical Tasks&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>On 16 March 2026, A peer-reviewed study published in Sensors reported that the NekSpine passive exoskeleton developed to support both the neck and lower back\u2014significantly reduced muscle strain and discomfort during tasks simulating the physical demands of surgery. The findings positioned NekSpine as a promising ergonomic solution for professionals such as surgeons, dentists, and industrial workers who frequently maintain forward-flexed postures for extended periods.<\/p>\n\n\n\n<p>The study was conducted by researchers from the University of Alberta in collaboration with EWI Works International Inc. The researchers assessed the device\u2019s performance across various neck-flexion angles using electromyography (EMG) sensors alongside user-reported exertion scores.<\/p>\n\n\n\n<p>The results demonstrated up to a 31% reduction in neck muscle activity at moderate flexion angles and up to a 19% reduction in lower-back muscle activity. Participants also reported a 50% decrease in neck discomfort and a 41% reduction in lower-back discomfort. Additionally, the use of the exoskeleton led to a 55% increase in endurance time, highlighting its effectiveness in improving comfort and sustaining performance during prolonged tasks.<\/p>\n\n\n\n<p>According to DelveInsight\u2019s \u201d<a href=\"https:\/\/www.delveinsight.com\/report-store\/wearable-medical-devices-markethttps:\/www.delveinsight.com\/report-store\/wearable-medical-devices-market\"><strong>Wearable Medical Devices Market Report<\/strong><\/a>,\u201d the global wearable medical devices market is expected to increase from <strong>USD 42,981.29 million<\/strong> in 2024 to <strong>USD 185,415.73 million<\/strong> by 2032, growing at a <strong>CAGR of 20.07%<\/strong> during the forecast period from 2025 to 2032. The global wearable medical devices market is surging, fueled by rising chronic disease prevalence, the shift toward remote patient monitoring, and rapid tech advances. With miniaturized sensors, AI-driven insights, and 5G connectivity, wearables are evolving from fitness gadgets into essential medical tools for proactive and connected healthcare.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-skinvision-collaborated-on-pivotal-trial-to-improve-access-to-dermatology-care-in-the-united-states-nbsp\"><span class=\"ez-toc-section\" id=\"SkinVision_Collaborated_on_Pivotal_Trial_to_Improve_Access_to_Dermatology_Care_in_the_United_States\"><\/span><strong>SkinVision Collaborated on Pivotal Trial to Improve Access to Dermatology Care in the United States&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>On 16 March 2026, SkinVision, a global provider of AI-powered skin health solutions, announced that it had entered into a research collaboration with Mayo Clinic to conduct a pivotal clinical study required by the U.S. Food and Drug Administration (FDA) to support its regulatory pathway in the United States. The collaboration was established under a formal research agreement aimed at facilitating scientific exchange and enabling the execution of an advanced clinical study.<\/p>\n\n\n\n<p>The initiative was launched in response to the rising incidence of melanoma and non-melanoma skin cancers, along with limited access to timely dermatology care in the U.S. Factors such as workforce shortages, insurance constraints, geographic disparities in dermatologist availability, and socioeconomic barriers had contributed to delayed diagnosis and poorer patient outcomes.<\/p>\n\n\n\n<p>The pivotal study was designed to evaluate the performance and intended use of the SkinVision app\u2019s AI-based assessment for skin lesions, while also assessing the role of digital tools in improving access to dermatological guidance. This collaboration marked a significant step in strengthening the company\u2019s clinical evidence base and advancing toward FDA clearance, to validate the application for use within the U.S. population.<\/p>\n\n\n\n<p>Additionally, the SkinVision app was developed to assist users in documenting and monitoring suspicious skin spots by guiding them to capture high-quality images and relevant information during self-examinations. The app provided indications when further evaluation by a healthcare professional was recommended, reinforcing the company\u2019s focus on delivering accessible, affordable, and research-driven digital skin health solutions.<\/p>\n\n\n\n<p>According to DelveInsight\u2019s \u201c<a href=\"https:\/\/www.delveinsight.com\/report-store\/dermatology-devices-market\"><strong>Dermatology Devices Market Report<\/strong><\/a>, the global dermatology devices market was valued at <strong>USD 6.27 billion<\/strong> in 2023, growing at a <strong>CAGR of 12.47%<\/strong> during the forecast period from 2024 to 2030 to reach <strong>USD 12.69 billion<\/strong> by 2030. The Dermatology Devices market is slated to witness prosperity owing to factors such as the growing prevalence of chronic skin problems such as acne, atopic dermatitis, and psoriasis among others, further increasing awareness of skin care and the growing focus on improving the safety and usability of dermatology devices for end-users are further expected to result in the appreciable revenue growth in the dermatology devices market during the forecast period from 2024 to 2030.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>MiniMed Announced the FDA Clearance of MiniMed Flex\u2122, the Company&#8217;s Smallest Insulin Pump Featuring its First Smartphone-Controlled Design&nbsp; On 18 March 2026, MiniMed announced that it had received clearance from the U.S. Food and Drug Administration (FDA) for its MiniMed Flex\u2122, a next-generation, discreet insulin pump designed for seamless integration into daily life. The device [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":34748,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[32],"tags":[22210,19511,19937,2753,17021,19823,12147,19740],"industry":[17226],"therapeutic_areas":[17237],"class_list":["post-34747","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizia","tag-dermatology-devices","tag-endoscopes","tag-insulin-infusion-pumps","tag-medical-device","tag-medical-devices-market","tag-spinal-fusion-devices","tag-ventilators","tag-wearable-medical-devices","industry-medical-devices","therapeutic_areas-dermatology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>MedTech News | MiniMed, Spinal Elements, Mindray<\/title>\n<meta name=\"description\" content=\"MiniMed\u2019s MiniMed Flex; Spinal Elements\u2019 Ventana Platform; Mindray\u2019s Entry in Ventilator Market; Composite Manufacturing\u2019s NekSpine\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/medtech-news-for-minimed-spinal-elements-mindray\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MedTech News | MiniMed, Spinal Elements, Mindray\" \/>\n<meta property=\"og:description\" content=\"MiniMed\u2019s MiniMed Flex; Spinal Elements\u2019 Ventana Platform; Mindray\u2019s Entry in Ventilator Market; Composite Manufacturing\u2019s NekSpine\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/medtech-news-for-minimed-spinal-elements-mindray\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-19T12:27:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.delveinsight.com\/blog\/wp-content\/uploads\/2026\/03\/medtech-news-for-minimed-spinal-elements-mindray.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"772\" \/>\n\t<meta property=\"og:image:height\" content=\"482\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Sandeep Joshi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sandeep Joshi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"12 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"MedTech News | MiniMed, Spinal Elements, Mindray","description":"MiniMed\u2019s MiniMed Flex; Spinal Elements\u2019 Ventana Platform; Mindray\u2019s Entry in Ventilator Market; Composite Manufacturing\u2019s NekSpine","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/medtech-news-for-minimed-spinal-elements-mindray","og_locale":"en_US","og_type":"article","og_title":"MedTech News | MiniMed, Spinal Elements, Mindray","og_description":"MiniMed\u2019s MiniMed Flex; Spinal Elements\u2019 Ventana Platform; Mindray\u2019s Entry in Ventilator Market; Composite Manufacturing\u2019s NekSpine","og_url":"https:\/\/www.delveinsight.com\/blog\/medtech-news-for-minimed-spinal-elements-mindray","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2026-03-19T12:27:00+00:00","og_image":[{"width":772,"height":482,"url":"https:\/\/www.delveinsight.com\/blog\/wp-content\/uploads\/2026\/03\/medtech-news-for-minimed-spinal-elements-mindray.webp","type":"image\/webp"}],"author":"Sandeep Joshi","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"Sandeep Joshi","Est. reading time":"12 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/medtech-news-for-minimed-spinal-elements-mindray","url":"https:\/\/www.delveinsight.com\/blog\/medtech-news-for-minimed-spinal-elements-mindray","name":"MedTech News | MiniMed, Spinal Elements, Mindray","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/medtech-news-for-minimed-spinal-elements-mindray#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/medtech-news-for-minimed-spinal-elements-mindray#primaryimage"},"thumbnailUrl":"https:\/\/www.delveinsight.com\/blog\/wp-content\/uploads\/2026\/03\/medtech-news-for-minimed-spinal-elements-mindray.webp","datePublished":"2026-03-19T12:27:00+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/f1eefd8dd4afdb0617d6166f8b301e0a"},"description":"MiniMed\u2019s MiniMed Flex; Spinal Elements\u2019 Ventana Platform; Mindray\u2019s Entry in Ventilator Market; Composite Manufacturing\u2019s NekSpine","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/medtech-news-for-minimed-spinal-elements-mindray"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/medtech-news-for-minimed-spinal-elements-mindray#primaryimage","url":"https:\/\/www.delveinsight.com\/blog\/wp-content\/uploads\/2026\/03\/medtech-news-for-minimed-spinal-elements-mindray.webp","contentUrl":"https:\/\/www.delveinsight.com\/blog\/wp-content\/uploads\/2026\/03\/medtech-news-for-minimed-spinal-elements-mindray.webp","width":772,"height":482,"caption":"medtech-news-for-minimed-spinal-elements-mindray"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/f1eefd8dd4afdb0617d6166f8b301e0a","name":"Sandeep Joshi","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7676451175fe155887a18ffb50e674b270d87436a3fc34ca206f86921cddf4cd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7676451175fe155887a18ffb50e674b270d87436a3fc34ca206f86921cddf4cd?s=96&d=mm&r=g","caption":"Sandeep Joshi"},"sameAs":["http:\/\/Delveinsight.com"]}]}},"author_meta":{"display_name":"Sandeep Joshi","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/sjoshidelveinsight-com"},"featured_img":"https:\/\/www.delveinsight.com\/blog\/wp-content\/uploads\/2026\/03\/medtech-news-for-minimed-spinal-elements-mindray-300x187.webp","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Notizia - Recent Pharma, Healthcare and Biotech Happenings<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Notizia - Recent Pharma, Healthcare and Biotech Happenings<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Dermatology Devices<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Endoscopes<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Insulin Infusion Pumps<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">medical device<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Medical Devices Market<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Spinal Fusion Devices<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">ventilators<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Wearable Medical Devices<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Dermatology Devices<\/span>","<span class=\"advgb-post-tax-term\">Endoscopes<\/span>","<span class=\"advgb-post-tax-term\">Insulin Infusion Pumps<\/span>","<span class=\"advgb-post-tax-term\">medical device<\/span>","<span class=\"advgb-post-tax-term\">Medical Devices Market<\/span>","<span class=\"advgb-post-tax-term\">Spinal Fusion Devices<\/span>","<span class=\"advgb-post-tax-term\">ventilators<\/span>","<span class=\"advgb-post-tax-term\">Wearable Medical Devices<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 2 months ago","modified":"Updated 2 months ago"},"absolute_dates":{"created":"Posted on Mar 19, 2026","modified":"Updated on Mar 19, 2026"},"absolute_dates_time":{"created":"Posted on Mar 19, 2026 5:57 pm","modified":"Updated on Mar 19, 2026 3:58 pm"},"featured_img_caption":"medtech-news-for-minimed-spinal-elements-mindray","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/34747","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=34747"}],"version-history":[{"count":1,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/34747\/revisions"}],"predecessor-version":[{"id":34749,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/34747\/revisions\/34749"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/34748"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=34747"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=34747"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=34747"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=34747"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=34747"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}